Author

G. Tjonnfjord

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Repetto· 1 shared E. Fiorito· 1 shared H. Heyerdahl· 1 shared J. Dahle· 1 shared J. T. Andersen· 1 shared R. Generaloc· 1 shared S. Foss· 1 shared S. S. Skanland· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Repetto

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NNV024, a novel humanized anti-CD37 antibody with enhanced ADCC and prolonged plasma half-life in human FcRn transgenic mice for treatment of NHL

R. Generaloc, E. Fiorito, S. Foss, V. Pascal, H. Heyerdahl, A. Repetto, J. T. Andersen, G. Tjonnfjord, S. S. Skanland, J. Dahle

This paper develops NNV024, a humanized anti-CD37 antibody with enhanced ADCC and prolonged plasma half-life, showing improved efficacy against NHL and CLL cells compared to existing therapies.

bioRxiv · Jul 12, 2023 · PreprintCancer Biology